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Summary Although cholesteatoma was ﬁrst described in 1683, its etiopathogeny remains
unexplained. In children, there are two forms: acquired cholesteatoma, resembling the adult
form, and congenital cholesteatoma. The acquired form has become less frequent in recent
years, thanks to progress in the treatment of childhood otitic pathology. Diagnosis of con-
genital cholesteatoma, on the contrary, is increasing, due to improvements in information
to health care professionals and in diagnostic tools. Clinical and histological evidence points
to greater aggressiveness in childhood forms, although this difference cannot, at present, be
precisely explained. Diagnosis is clinical, but CT and MR imaging is indispensable for preopera-
tive assessment and postoperative follow-up. New delayed gadolinium-enhanced T1-weighted
and diffusion-weighted MRI sequences have recently been developed and provide more pre-
cise radiological diagnosis. Treatment is surgical; alternatives, notably by laser, have proved
unsuccessful. Complications concern involvement of neighbouring structures, and are mainly
infectious; some can be life-threatening, and should be systematically screened.
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Introduction
Cholesteatoma is a severe middle-ear pathology affecting
both adults and children. It would seem to have been ﬁrst
described by De Verney in France in 1683, as what he called
‘‘steatoma’’ [1]. In 1829, the French anatomopathologist
Cruveilhier described it as a pearl tumor of the tempo-
ral bone [2]. The term ‘‘cholesteatoma’’, introduced in
1838 by the German physiologist Johannes Müller [3], is
now well established, but in fact, etymologically faulty in
∗ Corresponding author. Tel.: +33144736114; fax: +33144736108.
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s much as this benign tumor (‘‘. . .oma’’) contains nei-
her cholesterol (‘‘chole’’) nor fat (‘‘steat’’). In 1855,
irchow categorized cholesteatoma under epidermoid car-
inoma and atheroma, but only in 1861 did Von Troeltsch
onsider its epidermal origin. In the studies by Gruber,
endt and Rokitansky (1855—1888), the physiopathology of
holesteatoma was described as a malpighian metaplasia of
he middle-ear mucosa in response to chronic inﬂammation.
t the end of the 19th century, Bezold and Habermann over-
urned this theory, showing that cholesteatoma was caused
y migration of external auditory canal skin to the middle
ar, induced by chronic inﬂammation [4]. At the present
ime, despite numerous investigations, the physiopathology
f cholesteatoma has still not been elucidated.
.
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In children, there are two different types of
holesteatoma: acquired, which also affects adults,
nd congenital, which is speciﬁc to childhood. The most
ecent progress has been in imaging, with the introduction
f MRI in the early 2000s, followed by the recent develop-
ent of novel sequences. Treatment, on the other hand,
as not greatly progressed and remains mainly surgical.
pidemiology
ncidence is hard to determine, especially for congenital
holesteatoma. Recent ﬁgures testify to a fall in the inci-
ence of both adult and childhood acquired cholesteatoma:
n 1925, the rate of cholesteatoma in the under-16’s was one
n three; it is now much less frequent, but incidence in the
arly 2000s was still three per 100,000 (compared to nine
er 100,000 in adults) [5,6].
The incidence of congenital cholesteatoma, on the other
and, seems to be on the rise, at 0.12 per 100,000 children
7]. Some 1 to 3% of cases of childhood cholesteatoma, and
to 5% of cholesteatoma as a whole, are congenital [8].
The relative increase is due to the fall in the num-
er of cases of acquired cholesteatoma and an increase
n the diagnosis of congenital cholesteatoma. The latter
ncrease is thanks to the pathology being better known by
NT specialists and pediatricians; diagnostic tools, in partic-
lar microscopy, have improved, as has otologic follow-up of
hildren.
Prevalence varies between populations: it is highest
mong Caucasians, followed by Africans, and very low in
sians. Ratnesar reported extremely low prevalence of
holesteatoma in Inuits [9].
hysiopathology
holesteatoma is a non-neoplastic but destructive cys-
ic lesion containing keratin layers from a keratinized
alpighian epithelium surrounded by a matrix of epithelium
hat rests on a perimatrix formed of a conjunctive stroma
f varying thickness. It generally occurs in the middle ear,
ut other locations in or around the petrosal bone are also
ossible [6].
The pathologic substrate of cholesteatoma is a ker-
tinized stratiﬁed malpighian epithelium, the middle-
ar origin of which is, however, controversial. Various
tiopathogenic theories have been proposed to account for
he two forms of cholesteatoma. Despite recent research,
he underlying mechanisms remain unknown.
ongenital cholesteatoma
arious theories have been put forward to explain the for-
ation of congenital cholesteatoma. In 1854, Von Remak
ostulated that the origin of dermoid and other related
umors (such as cholesteatoma) was a skin follicle trapped
uring the early stages of embryogenesis [6].
Subsequently, many theories were formulated, culmi-
ating in that of epidermoid formation, close to Von
emak’s postulate, hypothesized by Teed in 1936 and then
y Michaels in 1986, and which remains the most widely
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ccepted theory. Both authors demonstrated the presence
f an epidermoid residue in the anterosuperior quadrant of
he middle ear in the human fetus, on the lateral wall of the
ustachian tube, near the annulus. Failure to reabsorb the
pidermoid residue normally found in embryos between the
0th and 33rd week of gestation has been observed [10,11].
cquired cholesteatoma
uring the course of the 20th century, four physiopatho-
ogical theories of the formation of acquired or secondary
holesteatoma were put forward. In 1864, Von Tröltsch ﬁrst
roposed a squamous metaplasia theory; in 1890, Haber-
ann and Bezold proposed the theory of migration or
nvasion; in 1925, Lange ﬁrst reported the phenomenon
nderlying the basal hyperplasia theory; and ﬁnally, in 1933,
ittmaack formulated the retraction pocket or invagination
heory, which is now the most widely accepted [6].
A1though there is no ﬁrmly established theory, primary
nd secondary acquired cholesteatoma are classically dis-
inguished: the former evolves from a retraction pocket,
hile the latter is due to epithelial migration through a rup-
ured ear-drum or to epithelium implanted in the middle
ar. Such implantation may be iatrogenic, occurring dur-
ng ear surgery, or due to epithelium left in the tympanic
avity after healing of a blast injury, or else arising post-
raumatically at a petrosal bone fracture site [4].
istopathologic differences between adult and
hildhood cholesteatoma
hildhood cholesteatoma has long been known to be more
ggressive than the adult form, with poorer clinical prog-
osis. Several studies have sought a physiopathological
xplanation for this ﬁnding [12—16].
According to Quaranta, the explanation lies in the
holesteatoma perimatrix. Following up this hypothesis, he
ound the number of mononuclear inﬂammation elements
plasmocytes, lymphocytes, macrophages, granulocytes and
iant cells) in the perimatrix to be greater in children than
n adults [17].
Bujia’s group analyzed the expression of MIB1 (a mon-
clonal antibody marker of cell proliferation) in child and
dult cholesteatoma and within the external auditory canal
kin; the proliferation index was normal in the latter, ele-
ated in the former, and relatively higher in children [14].
ecent studies conﬁrmed that the perimatrix is thicker and
he epithelium better contoured in child cholesteatoma
18].
Other studies, in contrast, found no signiﬁcant
istopathological differences between adults and chil-
ren in the matrix of acquired cholesteatoma that could
ccount for the difference in clinical aggressiveness [19].
rogress in histologyhere have been many studies of the cellular basis of the
peciﬁcities of childhood cholesteatoma, its local aggres-
iveness and growth potential. However, they have yet to
rovide an account that could enable medical treatment to
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be developed. There are, however, phenomena of hyper-
proliferation speciﬁc to middle-ear skin. Gene expression
studies conﬁrmed growth-factor and signalling molecule
upregulation. Likewise, protein expression studies demon-
strated elevated rates of the molecules involved in growth,
proliferation, antiapoptosis and bone resorption.
Recent breakthroughs have concerned angiogenesis and
metalloproteinases. These markers seem to explain the
difference in aggressiveness between childhood and adult
forms. In 2009, a Brazilian group demonstrated signiﬁcantly
elevated inﬂammation and metalloproteinase production in
childhood cholesteatoma; perimatrix angiogenesis, in terms
of blood-vessel count, was elevated in children. Metallopro-
teinases are proteolytic enzymes associated with pathologic
extracellular matrix resorption in chronic inﬂammation.
Inﬂammatory processes, such as infected cholesteatoma,
stimulate production of these enzymes. Dornelles’s group
demonstrated cytoplasmic hyperexpression of MMP2 (matrix
metalloproteinase) and nuclear hyperexpression of MMP2
and MMP9 in pediatric cholesteatoma. There also appears
to be a correlation between expression level and age: the
younger the child, the higher the cytoplasmic expression of
MMP2 in the cholesteatoma. Metalloproteinases are associ-
ated with the capacity to penetrate and invade neighboring
tissue. Their other role is to regulate bone homeostasis.
They are elevated in inﬂammatory osteolytic pathology. The
greater aggressiveness and osteolytic capacity of childhood
cholesteatoma would thus seem to derive from hyperexpres-
sion of perimatricial metalloproteinases [18].
The most recent studies have investigated the possi-
ble role of protein transcription regulators, micro-RNAs.
These RNA fragments of 22 to 24 nucleotide length, strongly
conserved over evolution and non-coding, inhibit protein
transcription. They play an essential role in cell regula-
tion pathways and are strongly implicated in oncogenesis.
In 2008, Ciofﬁ’s group reported signiﬁcant upregulation of
micro-RNA-21 (hsa-miR-21) in cholesteatoma as compared
to normal skin in humans, and proposed a growth and pro-
liferation model of cholesteatoma [20].
At the present time, the histologic and cellular phe-
nomena underlying the development of cholesteatoma and
its differential aggressiveness between childhood and adult
forms remain unknown.
Clinical aspect
Although cholesteatoma occurs mainly in the middle ear,
other locations are also possible. Classically, extra- and
intradural locations are distinguished. Extradural involve-
ment mainly concerns the middle ear, but may lie in any
part of the petrosal bone: mastoid, external auditory canal
or petrous apex. Intradural involvement, better known as
epidermoid cyst, has been reported at various locations,
the most frequent being the pontocerebellar angle. What-
ever the location, complex surgery is required, as there is
at present no medical treatment [4].Congenital cholesteatoma
In 1965, Derlacki and Clemis deﬁned congenital
cholesteatoma as an embryologic residue of epithelial
s
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[Figure 1 Congenital left-ear cholesteatoma.
issue behind a normal tympanic membrane, in the absence
f any history of infection or ear surgery [21]. They for-
ulated a series of diagnostic criteria: normal tympanic
embrane, retrotympanic white mass, and no history of
cute otitis media, otorrhea, eardrum rupture or otologic
urgery (Fig. 1). In 1986, these criteria were modiﬁed
y Levenson, who suggested that history of acute otitis
edia does not necessarily exclude diagnosis of congenital
holesteatoma, given its high frequency in young children
22]. Mean age at diagnosis is 4—5 years. Systematic recur-
ence of acute otitis media or otorrhea in the same ear is
n alarm signal.
According to Valvassori, congenital cholesteatoma can be
ound at four locations in the region of the petrosal bone:
iddle ear (middle ear cavity and mastoid), petrous apex,
ontocerebellar angle, and jugular foramen [23]. It is a rare
ongenital lesion, making up 1% of intracranial tumors. Forty
o 50% of cases are located in the pontocerebellar angle.
cquired cholesteatoma
arious classiﬁcations have been drawn up for acquired
holesteatoma, but there is not one, which is universally
mployed. Tos’s classiﬁcation, however, basing indications
n the location of the pathological process, seems to
e the most frequently used. It distinguishes three types
ccording to location: attic cholesteatoma, tympani sinus
holesteatoma with a posterior subligamentary starting
oint, and pars tensa cholesteatoma [24]. In children, 80%
f retraction pockets and cholesteatomas develop from or
epend on the pars tensa (especially the posterior subliga-
entary pars tensa) (Fig. 2), while in adults, they mainly
evelop in the pars ﬂaccid (or Shrapnell’s membrane) (Fig. 3)
25].
To cholesteatomas must be added unstable retraction
ockets, which are equivalent in as much as they have the
ame predictive factors as cholesteatoma. The clinical fea-
ures of these pockets are their marginal location, their
xation (outside of the ossicular chain), the impossibility of
omplete control, and associated otorrhea and/or squamata
25].
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fFigure 2 Acquired childhood cholesteatoma.
Acquired cholesteatoma is more aggressive in children,
or a number of reasons: it is often more extensive at diag-
osis; ossicular chain status is often poorer, due to more
xtensive ossicle lysis; and the rates of recurrence and resid-
al lesion are higher. This greater aggressiveness in children
as been explained in terms of childhood speciﬁcities in the
holesteatoma matrix and/or persisting predisposing factors
uch as impaired aeration of the ear [26].
Predictive factors for recurrence are large size and
xtension, age < 8 years, associated otorrhea, ossicular chain
tatus, and impaired preoperative aeration of the ear [27].
Predictive factors for residual lesion are initial posterior
id-tympanic invasion, ossicular chain interruption, lack of
xpertise on the part of the surgeon, and incomplete resec-
ion. The greater the association of these factors, the higher
he risk of residual lesion. In case of one risk factor, second-
ook surgery should systematically be performed within 12 to
8months. In case of two or more risk factors, second-look
urgery should be performed within 9months [25].Although cholesteatoma is more aggressive in children,
he number of local (labyrinthine ﬁstula or facial palsy) or
egional (intracranial) complications is lower [28].
Figure 3 Acquired adult cholesteatoma.
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Residual lesion and/or recurrence require long-term clin-
cal and radiological follow-up over at least 8 years [25].
Recurrence and residual lesion rates are higher in chil-
ren: for recurrence, the rate is 30%, versus 3 to 15% in
dults [29,30] and, for residual lesion, about 40% versus 15
o 20% in adults [31].
maging assessment
omputed tomography (CT)
emporal bone CT assesses cholesteatoma extension,
xploring for complications and detecting anatomic variants
o as to prepare for any difﬁculties in surgery. Diagnosis is
ormally clinical and otoscopic.
Technically, CT examination should be high-resolution,
on-contrast, with bone ﬁlter, with overlapping slices of sub-
r millimetric thickness in the axial (orbitomeatal plane:
.e., the plane of the lateral semi-circular canal) and coronal
lanes, orthogonally through the entire pars petrosa. Multi-
lice CT further requires submillimetric volume acquisition
entered on the pars petrosa, with the patient installed so
s to protect the orbits from radiation, with axial and coro-
al reconstruction in the plane of the lateral semi-circular
anal.[32,33]
The negative predictive value (NPV) of CT is excellent
34].
Cholesterol granuloma, however, which is frequently
ound in association with cholesteatoma, cannot be differ-
ntiated on CT; MRI enables the distinction.
The main CT criteria for cholesteatoma are: nodular
oft tissue mass within the tympano-mastoid cavities, with
ssociated osteolysis (wall of the epitympanic recess, and
ssicles, especially the long apophysis of the incus, tegmen
ympani and bone shell of the lateral semicircular canal)
35].
In case of doubt on ﬁrst examination, repeat scan per-
ormed a few months later detects growth of the residual
holesteatoma and thus provides better visualization.
The main limitation of CT is ﬂuid effusion in the mid-
le ear, hindering diagnosis of a residual lesion. MRI can
hen characterize soft tissue and differentiate between
holesteatoma and effusion.
One essential issue in CT is radioprotection, especially
n children presenting with chronic otitis media, requiring
umerous scans over their lifetime. This mainly concerns
he crystalline lens, and the risk of radio-induced cancer.
he crystalline lens is conserved with multislice CT, which
llows volume acquisition of the pars petrosa in a slice
lane excluding the orbit, with reconstruction in the classic
lice plane. Irradiation is standardized in petrous bone CT,
t about 8 years’ natural irradiation, whereas radioprotec-
ion standards give a risk threshold of more than 100 years
or natural radiation-induced cancer. This point needs to be
aken into account in the radiological follow-up of childhood
holesteatoma.RI
RI has more recently been introduced in cholesteatoma
ssessment, and is indicated for initial extension assess-
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ment, in case of contact with the meninges in particular, and
for postoperative follow-up in case of doubtful CT images.
MRI characteristics in cholesteatoma are: isosignal with
or without peripheral enhancement on post-gadolinium
T1-weighted sequences, and isosignal on T2-weighted
sequences. Associating delayed (30—50minutes, or ideally
45minutes according to certain authors) gadolinium-
enhanced T1-weighted sequences improved diagnosis of
residual cholesteatoma. The cholesteatoma never shows
enhancement, appearing in hyposignal with respect to sur-
rounding tissue.
In the last few years, a new type of sequence based on
the signal produced by displaced water molecules, known
as diffusion-weighted sequence, has provided further infor-
mation for residual lesion screening [34]. Cholesteatoma
shows as hypersignal on diffusion-weighted sequences. The
b-factor is usually b800 in children and b1,000 in adults.
The MRI resolution threshold is 3mm on standard
sequences, but just under 5mm on diffusion-weighted
sequences. The other limitations of this new sequence are
magnetic susceptibility artifacts and a T2 effect. These arti-
facts are related to the numerous air-bone interfaces due
to cranial base anatomy, inducing considerable distortion.
Mean sensitivity and speciﬁcity in classic diffusion-weighted
sequences are respectively 81.6% (range, 77 to 86%) and
100%, and positive predictive value (PPV) and NPV respec-
tively 100 and 75% [36].
To get around these limitations, an improved tech-
nique has been developed: turbo-spin echo (TSE) or
non-echo-planar (non-EPI) instead of echo-planar (EPI)
diffusion-weighted imaging [37]. This technique improves
spatial resolution, reducing the detection threshold to
3mm. PPV, NPV, sensitivity and speciﬁcity seem to be 100%.
Moreover, acquisition time is shorter, at about 3—4minutes,
compared to nearly 5—8minutes with the classical technique
[34].
Performing both CT and MRI is essential, as the aim is
to locate a tissue process within the temporal bone: CT
provides better spatial location, and MRI better tissue char-
acterization.
The power of most MRI machines used in everyday prac-
tice is 1.5 Tesla. With the development and purchasing
of new models, MRI at 3T or greater is becoming more
common and available. The usual advantage is shorter acqui-
sition time; but due to artifacts speciﬁc to this anatomic
region, diffusion-weighted sequence acquisition is paradoxi-
cally longer, incurring a risk of motion artifacts, especially in
children making interpretation tricky even for experienced
radiologists [38,39].
The two main problems with diffusion-weighted
sequences, whether classic or echoplanar, are the lack
of spatial resolution and the amount of artifacts. The
latter mainly concern bone/air and tissue/air interfaces.
The problems are partially resolved using TSE sequences,
although spatial resolution remains poor.
Examination duration and its requirements (sedation and
contention) are also important points. The time needed for
CT scan of the petrous bone varies greatly depending on the
equipment. In our experience of multislice CT, standard mil-
limetric acquisition takes approximately 30 secondes, and
submillimetric acquisition 70 secondes (such better resolu-
tion being needed notably to visualize the stapes). MRI takes
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pproximately 30minutes. In our experience, sedation is
mployed for CT in children under 3 years of age, and for MRI
n under-4-year-olds; older children can tolerate the exami-
ation if they and their parents have been properly informed
f the importance of the examination and how it takes place.
n case of difﬁculties of communication (such as associated
europsychiatric pathology or profound deafness), general
nesthesia is required (Table 1).
reatment
reatment remains surgical, although other options have
een tested. The prime objective is to eradicate the disease
o as to restore a healthy aerated ear. No less important, the
econd objective is to restore or improve the ossicular chain.
Since the ﬁrst description of mastoidectomy by Riolanus
n 1649, numerous procedures have been described. The
ain distinction, however, is whether or not to conserve the
osterior wall of the external auditory canal, distinguishing
anal wall-up tympanoplasty (with conservation) from canal
all-down tympanoplasty (non-conservation).
Middle-ear surgery is hampered in children by obstruction
f the Eustachian tube and chronic inﬂammatory hyper-
lasic mucosa, increasing the risk of incomplete resection
nd residual lesion. Fitting ventilation tubes ahead of
holesteatoma resection improves surgical preparation and
ostoperative course [40].
Cartilage should be used for eardrum reinforcement in
hildren, whereas the temporal aponeurosis is preferred in
dults. Posterior reinforcement is essential, given the pre-
onderance of recurrence and retraction in this area of the
ympanum. The problems encountered with cartilage are
ailure to control retrotympanic liquid effusion, and possible
esidual lesion [41,42].
Attempts at laser treatment, mainly to reduce the rate
f residual lesion in second-stage surgery, have not been
reatly followed up.
In 2005, Hamilton reported a signiﬁcant reduction in
esidual lesions, using the laser to control exeresis. He
pplied it speciﬁcally for ossicle locations and areas inac-
essible to classic surgery [43].
omplications
omplications are due to involvement of neighboring struc-
ures and to cholesteatoma location, and are generally of
nfectious origin. Classically, a distinction is drawn between
ntra- and extracranial complications, the latter being fur-
her divided into intra- and extratemporal complications
44].
xtratemporal complications
ubperiosteal abscess
ubperiosteal abscess is the most common extratemporal
omplication. It is caused by spread of infection from the
astoid towards the periosteal space by erosion of the
astoid cortex or, more rarely, by vascular propagation
econdary to mastoid emissary vein thrombosis. It is most
requent in young children. The clinical presentation is of
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lassical mastoiditis. Diagnosis is conﬁrmed by CT; treat-
ent is basically surgical, associating abscess drainage and
holesteatoma exeresis in a single step.
ezold’s abscess
ezold’s abscess is a cervical abscess, physiopathologically
dentical to a subperiosteal abscess, the only difference
eing a bone erosion area at the mastoid apex, which
xplains the extension to the neck below the sternocleido-
astoid muscle. It is more frequent in older children and
dults, due to the late pneumatization of the mastoid apex.
ike subperiosteal abscesses, it is more frequent in case of
cute otitis media but may also complicate cholesteatoma.
iagnosis and treatment are as in subperiosteal abscess,
ith one difference: the cervical incision.
ntra-temporal complications
abyrinthine ﬁstula is also very frequent, in 7% of
holesteatomas. The lateral semicircular canal is, due to its
ocation, the part of the labyrinth most frequently involved
in about 90% of cases), although superior and posterior
emicircular canal and cochlear locations have also been
eported. Otic capsule erosion may occur in two ways. Oste-
lysis mediators activated within the cholesteatoma matrix
r the pressure exerted by the cholesteatoma itself can lead
o osteolysis and uncovering of the labyrinth; or inﬂam-
ation mediators may induce resorption within the otic
apsule. Fistulae are not systematically seen on the CT (57 to
0%), which is not more indicative than patient interrogation
nd clinical examination. Treatment is surgical, associating
areful resection and coverage with aponeurosis and bone
âté, performed in the same step as cholesteatoma surgery.
he risk of hearing loss depends on ﬁstula location: it is 35%
n case of a promontory location and 3% when the location
s in the semicircular canals.
astoiditis
astoiditis is the internal equivalent of subperiosteal
bscess.
picitis (infection of the petrous apex) or petrositis
picitis (infection of the petrous apex) or petrositis is rare
ut dangerous, being located near to the middle and poste-
ior cranial fossae. The petrous apex is pneumatized in 30%
f patients, and such cells are in continuity with the mas-
oid cells and the middle ear, enabling infection to spread.
he classical clinical triad, known as Gradenigo’s syn-
rome, associates deep retro-orbital pain (50%), otorrhea
nd sixth cranial nerve palsy (25%). Primary treatment is
edical; in case of failure, bone necrosis or abscess, surgery
s required, with various approaches (infralabyrinthine,
etrolabyrinthine, supralabyrinthine or subpetrosal), using
xisting cells to reach the apex if hearing has been con-
erved.acial palsy
acial palsy is due to infection spreading by canal dehiscence
r to direct nerve compression by the cholesteatoma.
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Intracranial complications
Brain abscess
Brain abscess is the most frequent and most danger-
ous intracranial complication. Location is most frequently
temporal or cerebellar. Etiology is usually hematogenic dis-
semination secondary to thrombophlebitis, or in some cases
extension from subdural empyema following tegmen dehis-
cence. Evolution comprises three stages: encephalitis, then
a quiescent phase with subdued symptoms, with ﬁnal resur-
gence of symptoms in the form of elevated intracranial
pressure due to abscess rupture or extension. MRI is the most
suitable examination. Treatment associates broad-spectrum
antibiotics, corticosteroids to reduce the brain edema and
anticonvulsants. Emergency neurosurgical drainage is asso-
ciated to mastoidectomy if the patient is neurologically
stable enough. Frequent CT checks are the rule for moni-
toring.
Meningitis
Meningitis is the second most frequent complication.
Physiopathologically, there are three distinct extension
pathways: hematogenic (the most frequent), contiguity via
existing foramens and ﬁssures (Hyrtl’s ﬁssure), or bone ero-
sion. In 50% of cases, there is an associated intracranial
complication, to be explored for on contrast CT and MRI.
Treatment associates broad-spectrum antibiotics, corticos-
teroids to limit auditory and neurological sequelae, and
mastoidectomy.
Lateral or sigmoid sinus thrombosis
Lateral or sigmoid sinus thrombosis makes up 20% of
intracranial complications. The mechanism is either bone
erosion exposing the perisinus space, or spread of mas-
toid emissary vein thrombophlebitis. Intraluminal thrombi
induce secondary risk of hydrocephalus caused by extensive
sinus thrombosis and/or septic emboli (notably pulmonary).
Enhanced CT shows sinus wall uptake and ‘‘empty delta’’
sign. The exact extent of thrombus can be visualized on
angio-MRI. Treatment comprises at least mastoidectomy
associated to sinus denudation to drain the abscess. Surgery
is not performed on the thrombus itself. Control angio-MRI
is performed two weeks after initiation of treatment. Anti-
coagulants are a controversial issue, and are not currently
recommended except in case of sagittal sinus involvement or
signs of elevated intracranial pressure resistant to medical
treatment.
Subdural abscess or empyema
Subdural abscess or empyema is induced by bone dehis-
cence. Signs (worsening ear- and head-ache) are often
rudimentary, with insidious development. Diagnosis is by CT.
Treatment is surgical, mastoidectomy enabling the abscess
bone cover to be excised.
Otitic hydrocephalus
Otitic hydrocephalus is another complication. Its phys-
iopathology is unclear. Development is due to superior
sagittal sinus inﬂammation or infection blocking CSF resorp-
tion by the arachnoid villi in the Pacchioni granulations,
inducing intracranial pressure elevation. Diagnosis and
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reatment are as in intracranial pressure elevation in gen-
ral. Diagnosis is based on an association of intracranial
ressure elevation, its clinical symptomatology and papil-
ary edema in the absence of ventricular dilatation or signs
f meningitis. Angio-MRI conﬁrms venous sinus thrombosis.
reatment targets the ear infection and brain pressure and
revention of catastrophic impact on the optic nerve. Gen-
ral anticoagulation therapy is recommended only in case of
uperior longitudinal sinus thrombosis.
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